SEI Investments’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $538K | Buy |
63,401
+39,467
| +165% | +$263K | ﹤0.01% | 2605 |
|
|
2026
Q1 | $130K | Sell |
23,934
-50,196
| -68% | -$282K | ﹤0.01% | 3048 |
|
|
2025
Q4 | $519K | Sell |
74,130
-23,154
| -24% | -$181K | ﹤0.01% | 2494 |
|
|
2025
Q3 | $752K | Buy |
97,284
+58,380
| +150% | +$456K | ﹤0.01% | 2078 |
|
|
2025
Q2 | $339K | Buy |
38,904
+18,833
| +94% | +$137K | ﹤0.01% | 2359 |
|
|
2025
Q1 | $160K | Buy |
20,071
+1,808
| +10% | +$18.3K | ﹤0.01% | 2507 |
|
|
2024
Q4 | $166K | Buy |
18,263
+1,506
| +9% | +$14.5K | ﹤0.01% | 2508 |
|
|
2024
Q3 | $154K | Sell |
16,757
-4,633
| -22% | -$38.3K | ﹤0.01% | 2516 |
|
|
2024
Q2 | $209K | Sell |
21,390
-1,127
| -5% | -$13.7K | ﹤0.01% | 2444 |
|
|
2024
Q1 | $340K | Buy |
22,517
+8,550
| +61% | +$155K | ﹤0.01% | 2256 |
|
|
2023
Q4 | $301K | Sell |
13,967
-1,377
| -9% | -$25.4K | ﹤0.01% | 2304 |
|
|
2023
Q3 | $285K | Sell |
15,344
-20,369
| -57% | -$475K | ﹤0.01% | 2315 |
|
|
2023
Q2 | $904K | Buy |
35,713
+25,537
| +251% | +$643K | ﹤0.01% | 1910 |
|
|
2023
Q1 | $264K | Buy |
+10,176
| New | +$272K | ﹤0.01% | 2391 |
|
|
2022
Q2 | – | Sell |
-9,152
| Closed | -$597K | – | 2724 |
|
|
2022
Q1 | $597K | Buy |
9,152
+2,388
| +35% | +$172K | ﹤0.01% | 2010 |
|
|
2021
Q4 | $542K | Buy |
6,764
+767
| +13% | +$91.7K | ﹤0.01% | 2069 |
|
|
2021
Q3 | $765K | Sell |
5,997
-1,101
| -16% | -$160K | ﹤0.01% | 1880 |
|
|
2021
Q2 | $1.27M | Buy |
7,098
+2,174
| +44% | +$352K | ﹤0.01% | 1701 |
|
|
2021
Q1 | $956K | Sell |
4,924
-40,600
| -89% | -$9.42M | ﹤0.01% | 1773 |
|
|
2020
Q4 | $9.12M | Sell |
45,524
-633
| -1% | -$129K | 0.02% | 680 |
|
|
2020
Q3 | $10.1M | Buy |
46,157
+10,536
| +30% | +$2.23M | 0.03% | 535 |
|
|
2020
Q2 | $6.8M | Sell |
35,621
-23,530
| -40% | -$4.12M | 0.02% | 716 |
|
|
2020
Q1 | $9.17M | Sell |
59,151
-20,125
| -25% | -$2.34M | 0.03% | 497 |
|
|
2019
Q4 | $6.64M | Sell |
79,276
-14,647
| -16% | -$1.11M | 0.02% | 764 |
|
|
2019
Q3 | $6.37M | Sell |
93,923
-1,752
| -2% | -$115K | 0.02% | 815 |
|
|
2019
Q2 | $6.37M | Buy |
95,675
+54,810
| +134% | +$3.19M | 0.02% | 808 |
|
|
2019
Q1 | $2.29M | Buy |
40,865
+26,739
| +189% | +$1.63M | 0.01% | 1253 |
|
|
2018
Q4 | $1.13M | Buy |
14,126
+949
| +7% | +$58.1K | ﹤0.01% | 1487 |
|
|
2018
Q3 | $1.14M | Sell |
13,177
-14,308
| -52% | -$1.02M | ﹤0.01% | 1424 |
|
|
2018
Q2 | $1.6M | Buy |
27,485
+21,769
| +381% | +$1.06M | 0.01% | 1413 |
|
|
2018
Q1 | $231K | Buy |
5,716
+3,343
| +141% | +$126K | ﹤0.01% | 1844 |
|
|
2017
Q4 | $83K | Buy |
2,373
+1,030
| +77% | +$34.2K | ﹤0.01% | 2211 |
|
|
2017
Q3 | $45K | Hold |
1,343
| – | – | ﹤0.01% | 2302 |
|
|
2017
Q2 | $47K | Hold |
1,343
| – | – | ﹤0.01% | 2264 |
|
|
2017
Q1 | $34K | Hold |
1,343
| – | – | ﹤0.01% | 2223 |
|
|
2016
Q4 | $22K | Hold |
1,343
| – | – | ﹤0.01% | 2321 |
|
|
2016
Q3 | $25K | Buy |
+1,343
| New | +$23.6K | ﹤0.01% | 2223 |
|
Other funds holding TDOC
VC
SEI Investments's TDOC Position: Q2 2026 in Review
SEI Investments increased its Teladoc Health (TDOC) stake by 165% in Q2 2026, buying an estimated $263K and bringing the position to 63,401 shares worth $538K. The position accounts for ﹤0.01% of the portfolio, ranked #2605.
SEI Investments first reported a position in TDOC in Q3 2016 and has held it in 37 quarters since. The position peaked at $10.1M in Q3 2020. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.
- SEI Investments held 63,401 shares of Teladoc Health worth $538K as of Q2 2026.
- SEI Investments bought 39,467 Teladoc Health shares in Q2 2026, an estimated $263K.
- Teladoc Health made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2605 holding.
- SEI Investments first reported a position in Teladoc Health in Q3 2016 and has held it in 37 quarters since.
- SEI Investments's Teladoc Health position peaked at $10.1M in Q3 2020.
- 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.